DOW vs FBLG · P/E 74, rev $39.97B vs $24.0M cap
Dow Inc (DOW) versus FibroBiologics, Inc. Common Stock (FBLG) — a side-by-side from cached financials, not a winner call.
Dow Inc (DOW) is a chemicals company listed on US.
FibroBiologics, Inc. Common Stock (FBLG) is a biotechnology company listed on US.
Latest reported DOW revenue for 2025-12-31 was $39.97B. Net income was -$2.44B. Revenue was down 7.0% from 2024-12-31 to 2025-12-31. DOW currently screens at market cap $20.89B and trailing P/E 73.9.
FBLG does not have a complete income-statement cache yet.
DOW currently screens at market cap $20.89B and trailing P/E 73.9. FBLG currently screens at market cap $24.0M.
Not investment advice. Open the DOW and FBLG stock pages for the full models.
Not investment advice.